Total
0
Shares
Creso Pharma (ASX:CPH) - Outgoing CEO & Co Founder, Dr Miri Halperin Wernli (left) and Chairman, Boaz Wachtel (right) - The Market Herald
Outgoing CEO & Co Founder, Dr Miri Halperin Wernli (left) and Chairman, Boaz Wachtel (right)
Source: YouTube
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Creso Pharma (CPH) is making further inroads into the Canadian cannabis market with its products being added to the Ontario Cannabis Store's stock list
  • Creso's subsidiary Mernova has been selected as an official supplier to the Ontario Cannabis Retail Corporation (OCRC), acting as the Ontario Cannabis Store (OCS)
  • The monopoly provider services Canada's largest recreational cannabis market through both brick-and-mortar shopfronts and an online store
  • Monthly sales in September alone totalled almost C$80 million (around A$81 million), accounting for over 30 per cent of Canada's total consumption
  • Under the agreement, Mernova will supply its Ritual Green range of artisanal cannabis strains to the OCS, with first orders expected imminently
  • While volume commitments are still yet to be finalised, Creso and Mernova anticipate strong sales growth in the near-term
  • Creso Pharma closed Wednesday's session 6.38 per cent lower at 22 cents

Creso Pharma (CPH) is making further inroads into the Canadian cannabis market with its products being added to the Ontario Cannabis Store's stock list.

Ritual Green

Creso's Canadian subsidiary, Mernova, has been selected as an official supplier to the Ontario Cannabis Retail Corporation (OCRC), acting as the Ontario Cannabis Store (OCS).

The store services Ontario through both brick-and-mortar shopfronts and an online store, supplying Canada's largest recreational cannabis market.

The OCS is Ontario’s only retailer and wholesaler of legal recreational cannabis.

Monthly sales in September alone totalled almost C$80 million (around A$81 million), accounting for over 30 per cent of Canada's total consumption.

Under the agreement, Mernova will supply its Ritual Green range of artisanal cannabis strains to the OCS, with first orders expected imminently.

Mernova Managing Director Jack Yu says the OCS deal is a huge step for Mernova in increasing its market presence.

"To be able to compete in a market with over C$385 million [around A$400 million] in sales between April 2019 and March 2020, which continues to grow, as evidenced by over C$80 million in sales this past September alone, is a huge opportunity for us and we look forward to firmly establishing ourselves as one of the premier cannabis producers in the country," Jack said.

"We look forward to greatly expanding the reach and distribution of our Ritual Green products, that more consumers can experience the premium products that Creso Pharma and Mernova have to offer," he added.

Outlook

While volume commitments are still yet to be finalised, Creso and Mernova anticipate strong sales growth in the near-term.

With a sealed deal to supply the monopoly provider of Canada's biggest legal recreational cannabis market, Creso's North American foray is showing more than just green shoots — it's looking like high times ahead.

Creso Pharma closed Wednesday's session 6.38 per cent lower at 22 cents.

More From The Market Herald
Little Green Pharma (ASX:LGP) - Managing Director, Fleta Solomon - The Market Herald

" Little Green Pharma (ASX:LGP) pursues global expansion over June quarter

Little Green Pharma (LGP) celebrated backing from Gina Rhineheart and a major medicinal cannabis facility purchase over the June quarter but noted subdued

" Chimeric Therapeutics (ASX:CHM) obtains licence for solid tumour cell therapy

Chimeric Therapeutics (CHM) has obtained the exclusive licence to a novel treatment for solid tumours from the University of Pennsylvania.  
AnteoTech (ASX:ADO) - CEO, Derek Thomson - The Market Herald

" AnteoTech (ASX:ADO) strikes UK distribution deal for COVID-19 test tech

Surface chemistry company AnteoTech (ADO) has struck its first European distribution deal for its EuGeni rapid diagnostic test (RDT) technology.
Audio Pixels (ASX:AKP) completes speaker wafer testing

" Audio Pixels (ASX:AKP) readies technology for in-person demonstrations

Digital loudspeaker developer, Audio Pixels (AKP) has announced it is continuing to upgrade its demonstration systems by incorporating recently packaged transducers.